"10.1371_journal.pone.0043809","plos one","2012-08-24T00:00:00Z","Stephen J McWilliam; Daniel J Antoine; Venkata Sabbisetti; Mark A Turner; Tracey Farragher; Joseph V Bonventre; B Kevin Park; Rosalind L Smyth; Munir Pirmohamed","MRC Centre for Drug Safety Science, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom; Department of Medicine, Renal Division, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Department of Womens and Childrens Health, Neonatal Unit, Liverpool Womens Hospital, University of Liverpool, Liverpool, United Kingdom; Leeds Institute of Health Sciences, University of Leeds, Leeds, United Kingdom; Institute of Child Health, Department of Womens and Childrens Health, University of Liverpool, Liverpool, United Kingdom","Conceived and designed the experiments: SJM DJA MT TF RLS BKP MP. Performed the experiments: SJM DJA VS. Analyzed the data: SJM DJA VS MT TF JVB RLS BKP MP. Contributed reagents/materials/analysis tools: DJA JVB BKP MP. Wrote the paper: SJM DJA VS MT JVB RLS BKP MP.","JVB is a co-inventor on KIM-1 patents assigned to Partners Healthcare and licensed to Sekisui, Johnson and Johnson and Biogenldec and a number of research reagent companies. The research reagent companies are MesoScale diagnostics, R&D systems, Cell biolabs Inc and Argutus Medical LTD (Molecules and methods for inhibiting shedding of KIM-1; Kidney injury-related molecules; Modulators of tissue regeneration). He is a consultant to Sekisui. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","08","Stephen J McWilliam","SJMW",9,TRUE,7,3,9,8,TRUE,TRUE,FALSE,0,NA,FALSE
